Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A dopa-responsive dystonia characterized by marked motor delay, but no intellectual disability, and only minimal, if any, hyperphenylalaninemia.
Biomarker and diagnostic research for dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive has been reported in the published literature.
No clinical trials have been registered for dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive.
54 publications have been identified in PubMed for dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive. Research spans Case Report / Case Series (28%), Epidemiology / Natural History (20%), and Basic Science / Preclinical (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 15 |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 1:02 AM UTC
Disease patterns and progression | 11 | 20% |
Laboratory research | 9 | 17% |
Research summaries | 7 | 13% |
Clinical study results | 5 | 9% |
Testing and diagnosis research | 4 | 7% |
New treatment approaches | 3 | 6% |
Veleva D (2026). [PMID: 41364952](https://pubmed.ncbi.nlm.nih.gov/41364952/). *Stem cell research*. [Basic Science / Preclinical]
Ślusarczyk K (2026). [PMID: 41581294](https://pubmed.ncbi.nlm.nih.gov/41581294/). *Molecular genetics and metabolism*. [Epidemiology / Natural History]
Ren R (2026). [PMID: 41988854](https://pubmed.ncbi.nlm.nih.gov/41988854/). *Int J Dev Neurosci*. [Case Report / Case Series]
Jones H (2026). [PMID: 42123950](https://pubmed.ncbi.nlm.nih.gov/42123950/). *Nutrients*. [Review / Meta-Analysis]
Ali Ismail AM (2026). [PMID: 41793924](https://pubmed.ncbi.nlm.nih.gov/41793924/). *Med Clin (Barc)*. [Clinical Trial Publication]
Giret C (2026). [PMID: 41421263](https://pubmed.ncbi.nlm.nih.gov/41421263/). *Molecular genetics and metabolism*. [Epidemiology / Natural History]
Almenabawy N (2026). [PMID: 41688735](https://pubmed.ncbi.nlm.nih.gov/41688735/). *Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology*. [Case Report / Case Series]
Li M (2026). [PMID: 42154052](https://pubmed.ncbi.nlm.nih.gov/42154052/). *Neurol Sci*. [Case Report / Case Series]
Manti F (2026). [PMID: 41450729](https://pubmed.ncbi.nlm.nih.gov/41450729/). *Neurology. Genetics*. [Clinical Trial Publication]
Karaca M (2026). [PMID: 41723557](https://pubmed.ncbi.nlm.nih.gov/41723557/). *Hum Genomics*. [Review / Meta-Analysis]